[1]张丽君,王 蓉,章 峰.左卡尼汀注射液对维持性血液透析患者微炎症状态、营养不良及氧化应激的影响[J].陕西医学杂志,2022,51(8):1004-1007.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.023]
 ZHANG Lijun,WANG Rong,ZHANG Feng.Effect of Levocanidine injection on microinflammatory state,malnutrition and oxidative stress in patients undergoing maintenance hemodialysis[J].,2022,51(8):1004-1007.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.023]
点击复制

左卡尼汀注射液对维持性血液透析患者微炎症状态、营养不良及氧化应激的影响
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年8期
页码:
1004-1007
栏目:
药物与临床
出版日期:
2022-08-05

文章信息/Info

Title:
Effect of Levocanidine injection on microinflammatory state,malnutrition and oxidative stress in patients undergoing maintenance hemodialysis
作者:
张丽君王 蓉章 峰
(汉中市中心医院,陕西 汉中723000)
Author(s):
ZHANG LijunWANG RongZHANG Feng
(Hanzhong Central Hospital,Hanzhong 723000,China)
关键词:
肾功能不全失代偿期 维持性血液透析 左卡尼汀注射液 微炎症状态 营养不良 氧化应激
Keywords:
Decompensated stage of renal insufficiency Maintenance hemodialysis Levocanidine injection Microinflammatory state Malnutrition Oxidative stress
分类号:
R 625.9
DOI:
DOI:10.3969/j.issn.1000-7377.2022.08.023
文献标志码:
A
摘要:
目的:探讨左卡尼汀注射液对维持性血液透析患者机体微炎症状态、营养不良及氧化应激程度的影响,为肾功能不全失代偿期患者的透析治疗提供依据。方法:307例肾功能不全失代偿期维持性透析患者随机分为对照组153例、观察组154例,对照组接受常规治疗,观察组在常规治疗的基础上予以左卡尼汀注射液2 g,静脉注射,隔日1次,连续治疗3个月。比较两组患者治疗前后炎性因子、营养指标及氧化应激指标的变化。结果:两组治疗前血清炎性因子[C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)]水平、营养指标[白蛋白(Alb)、前白蛋白(PA)、血红蛋白(Hb)]水平以及氧化应激指标[谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)、超氧化物歧化酶(SOD)]水平比较均无统计学差异(均P>0.05); 治疗后两组炎性因子CRP、TNF-α及IL-6水平均降低,营养指标Alb、PA及Hb水平均升高,氧化应激指标GSH-Px、SOD水平均升高,MDA水平均降低,观察组各指标变化更为显著,与对照组治疗后各指标比较,差异均有统计学意义(均P<0.01)。结论:左卡尼汀在维持性血液透析治疗过程中能较好地改善患者微炎症状态、营养不良及机体的氧化应激状态,改善患者的生存质量。
Abstract:
Objective:To investigate the effect of Levocanidine injection on microinflammation,malnutrition and oxidative stress in patients undergoing maintenance hemodialysis,and to provide basis for dialysis treatment in patients with decompensated renal insufficiency.Methods:A total of 307 patients with decompensated renal insufficiency undergoing maintenance dialysis were randomly divided into control group(153 cases)and observation group(154 cases).The control group received conventional treatment,while the observation group received 2 g Levocanidine injection intravenously once every other day on the basis of conventional treatment for 3 months.The changes of inflammatory factors,nutritional indexes and oxidative stress indexes before and after treatment were compared between the two groups.Results:Before treatment,the levels of serum inflammatory factors [C-reactive protein(CRP),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)],nutritional indexes [albumin(Alb),prealbumin(PA),hemoglobin(Hb)]and oxidative stress indexes [glutathione peroxidase(GSH-Px),malondialdehyde(MDA),superoxide dismutase(SOD)] were not statistically different between the two groups(all P>0.05).After treatment,the levels of CRP,TNF-α and IL-6 in the two groups were decreased,the levels of Alb,PA and Hb were increased,the levels of GSH-Px and SOD were increased,and the level of MDA was decreased,and the changes of the above indexes in the observation group were more significant than those in the control group(all P<0.01).Conclusion:Levocanidine can improve the microinflammatory state,malnutrition and oxidative stress state of patients during maintenance hemodialysis treatment,and improve the quality of life of patients.

参考文献/References:

[1] 刘香红.高通量血液透析对终末期肾病患者微炎性状态及细胞免疫的影响分析[J].中国医学工程,2021,29(1):93-96.
[2] 罗 楠,李新伦,陈凤锟,等.维持性血液透析相关肌肉减少症的患病率及危险因素的横断面调查[J].中国血液净化,2021,20(8):536-545.
[3] 舒亮辉,王星月,王 云,等.PDCA循环管理对基层医院维持性血液透析患者矿物质代谢及营养指标改善的疗效观察[J].中国血液净化,2021,20(5):351-355.
[4] 曹云松,丁昕宇,任 可.“养阴三法”治疗规律血液透析患者难治性高血压的经验浅谈[J].陕西中医,2015,36(3):336-338.
[5] 邓莉莉,廖晓辉,韩显文.高通量透析对尿毒症维持性血透患者的血脂及C-反应蛋白的分析研究[J].检验医学与临床,2015,12(11):1585-1586.
[6] 崔 俊,亢宁苏,周春霞,等.高通量血液透析联合百令胶囊对糖尿病肾病血液透析患者氧化应激、微炎性状态及生存质量的影响[J].疑难病杂志,2020,19(8):764-768.
[7] 宋家志,刘 婧,张丽涓,等.血液透析患者心血管标志物水平变化与其预后的相关性研究[J].内科急危重症杂志,2017,23(5):410-412.
[8] 王宇静,蔡 枫,李 兆,等.维持性血液透析患者缺铁状态与微炎症的相关性研究[J].中华医院感染学杂志,2016,26(2):372-373.
[9] 南 静.左卡尼汀联合阿托伐他汀钙对维持性血液透析患者微炎性反应状态的影响[J].中国医师进修杂志,2015,38(4):298-300.
[10] 刘绍芳,李金香,陈海燕,等.不同透析方式对MHD患者尿毒症毒素清除、炎症因子和氧化应激状态的影响[J].分子诊断与治疗杂志,2021,13(10):1656-1659.
[11] 张 媛,朱小静.维持性血液透析患者骨硬化蛋白、Klotho蛋白水平变化及与冠状动脉钙化相关性分析[J].陕西医学杂志,2021,50(10):1246-1249.
[12] 朱智峰.血液灌流+血液透析对长期血液透析患者免疫功能、Ca及P代谢的影响[J].世界最新医学信息文摘,2019,19(42):138-141.
[13] 郝 静,夏京华.加味桃红四物汤联合左卡尼汀对维持性血液透析患者营养状况的影响[J].陕西中医,2021,42(7):903-906.
[14] 王佳莹,谭 峰,吴宸极,等.维持性血液透析伴继发性甲状旁腺功能亢进患者甲状旁腺切除术后骨饥饿综合征发生影响因素及血清离子变化特征[J].陕西医学杂志,2021,50(3):334-337.
[15] Vasiljevski ER,Burns J,Bray P,et al.L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1:A phase 2a clinical trial[J].American Journal of Medical Genetics,2021,185(10):2976-2985.
[16] Mansour H,Shereen M,Ibrahim AB,et al.Effect of L-carnitine on cardiotoxicity and apoptosis induced by imatinib through PDGF/PPARγ/MAPK pathways[J].Archives of Biochemistry and Biophysics,2021,704:108866.
[17] Wang DD,Mao YZ,He SM,et al.Quantitative efficacy of L-carnitine supplementation on glycemic control in type 2 diabetes mellitus patients[J].Expert Review of Clinical Pharmacology,2021,14(7):1-8.
[18] Baghban F,Hosseinzadeh F,Mozaffari KH,et al.The effect of L-carnitine supplementation on clinical symptoms,C-reactive protein and malondialdehyde in obese women with knee osteoarthritis:A double blind randomized controlled trial[J].BMC Musculoskeletal Disorders,2021,22(1):195.
[19] 徐 维,袁立英,喻海燕.前列地尔联合肾康注射液对维持性血液透析老年患者微炎症状态的影响[J].中国老年学杂志,2021,41(19):4308-4311.
[20] Yan Z,Chao X,Ou JH,et al.Effect of l-carnitine supplementation on renal anemia in patients on hemodialysis:A meta-analysis[J].International Urology and Nephrology,2021,53(10):1-8.
[21] Sugiyama M,Hazama T,Nakano K,et al.Effects of reducing L-carnitine supplementation on carnitine kinetics and cardiac function in hemodialysis patients:A multicenter,single-blind,placebo-controlled,randomized clinical trial[J].Nutrients,2021,13(6):1900.

相似文献/References:

[1]罗孔认,陈梦诗,陈珊娜.甲壳质酶蛋白40、中性粒细胞载脂蛋白及基质金属蛋白酶-9水平与尿毒症维持性血液透析患者感染相关性研究[J].陕西医学杂志,2023,52(10):1362.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.017]
 LUO Kongren,CHEN Mengshi,CHEN Shanna.Correlation of YKL-40,NGAL and MMP-9 levels with infection in uremic patients undergoing maintenance hemodialysis[J].,2023,52(8):1362.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.017]

备注/Memo

备注/Memo:
基金项目:陕西省科技计划项目(2014JQ4152)
更新日期/Last Update: 2022-08-04